Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
Pouteil-Noble
C
C
Nephrology-Transplantation Unit, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.
Megas
F
F
Chapuis
F
F
Bosshard
S
S
Colin
C
C
Hadj-Aissa
A
A
Pozet
N
N
Martin
X
X
Lefrançois
N
N
Garnier
J L
JL
Aymard
M
M
Touraine
J L
JL
D000212:Acyclovir / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000145:classification / Q000453:epidemiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation; D010919:Placebos; D011183:Postoperative Complications; D011336:Probability
D000998:Antiviral Agents; D010919:Placebos; D015774:Ganciclovir; D000212:Acyclovir